Annual ROE
-44.15%
-3.97%-9.88%
December 31, 2024
Summary
- As of March 9, 2025, RLAY annual return on equity is -44.15%, with the most recent change of -3.97% (-9.88%) on December 31, 2024.
- During the last 3 years, RLAY annual ROE has fallen by -0.34% (-0.78%).
- RLAY annual ROE is now -200.39% below its all-time high of 43.98%, reached on December 31, 2018.
Performance
RLAY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.37%
+1.38%+3.02%
December 31, 2024
Summary
- As of March 9, 2025, RLAY quarterly return on equity is -44.37%, with the most recent change of +1.38% (+3.02%) on December 31, 2024.
- Over the past year, RLAY quarterly ROE has dropped by -0.71% (-1.63%).
- RLAY quarterly ROE is now -110.94% below its all-time high of 405.66%, reached on June 30, 2020.
Performance
RLAY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RLAY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.9% | -1.6% |
| 3 y3 years | -0.8% | +12.6% |
| 5 y5 years | -205.8% | -206.3% |
RLAY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.4% | at low | -36.5% | +15.3% |
| 5 y | 5-year | -205.8% | at low | -110.9% | +60.0% |
| alltime | all time | -200.4% | at low | -110.9% | +60.0% |
Relay Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -44.15%(+9.9%) | -44.37%(-3.0%) |
| Sep 2024 | - | -45.75%(+4.8%) |
| Jun 2024 | - | -43.66%(+5.3%) |
| Mar 2024 | - | -41.45%(+1.2%) |
| Dec 2023 | -40.18%(+27.8%) | -40.96%(+11.1%) |
| Sep 2023 | - | -36.86%(-5.3%) |
| Jun 2023 | - | -38.93%(+7.5%) |
| Mar 2023 | - | -36.22%(+11.4%) |
| Dec 2022 | -31.44% | -32.50%(-8.5%) |
| Sep 2022 | - | -35.51%(-1.4%) |
| Jun 2022 | - | -36.01%(-31.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -52.39%(+3.2%) |
| Dec 2021 | -43.81%(+143.7%) | -50.77%(+32.2%) |
| Sep 2021 | - | -38.41%(+14.9%) |
| Jun 2021 | - | -33.43%(+137.9%) |
| Mar 2021 | - | -14.05%(+6.4%) |
| Dec 2020 | -17.98%(-143.1%) | -13.21%(-81.0%) |
| Sep 2020 | - | -69.41%(-117.1%) |
| Jun 2020 | - | 405.66%(-465.5%) |
| Mar 2020 | - | -110.99%(-366.0%) |
| Dec 2019 | 41.73%(-5.1%) | 41.73% |
| Dec 2018 | 43.98% | - |
FAQ
- What is Relay Therapeutics annual return on equity?
- What is the all time high annual ROE for Relay Therapeutics?
- What is Relay Therapeutics annual ROE year-on-year change?
- What is Relay Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Relay Therapeutics?
- What is Relay Therapeutics quarterly ROE year-on-year change?
What is Relay Therapeutics annual return on equity?
The current annual ROE of RLAY is -44.15%
What is the all time high annual ROE for Relay Therapeutics?
Relay Therapeutics all-time high annual return on equity is 43.98%
What is Relay Therapeutics annual ROE year-on-year change?
Over the past year, RLAY annual return on equity has changed by -3.97% (-9.88%)
What is Relay Therapeutics quarterly return on equity?
The current quarterly ROE of RLAY is -44.37%
What is the all time high quarterly ROE for Relay Therapeutics?
Relay Therapeutics all-time high quarterly return on equity is 405.66%
What is Relay Therapeutics quarterly ROE year-on-year change?
Over the past year, RLAY quarterly return on equity has changed by -0.71% (-1.63%)